GE Healthcare and Dyax have signed a licensing agreement for the development and commercialization of peptides binding to c-Met, which provides upfront, milestone and royalty payments to Dyax. The license includes application of the peptides in PET, SPECT and optical imaging.

Biospace Lab in Paris and the Centre for Advanced Biomedical Imaging at University College London will collaborate on the development of real-time in vivo optical imaging applications and further development of the Biospace Lab PhotonImager Optima preclinical imaging platform.

As part of a $4.5 million, nine-year effort to employ molecular imaging and nanotechnology in developing “theragnosis”—simultaneous diagnostics and therapeutics—partnering research teams from Purdue University’s Discovery Park and the Korean Institute of Science and Technology will hold a daylong symposium, Sept. 6, in West Lafayette, Ind.